Concepedia

Publication | Open Access

Peginterferon Alfa-2a in Patients with Chronic Hepatitis C and Cirrhosis

DOIFull Paper Access

885

Citations

15

References

2000

Year

E. Jenny Heathcote, Mitchell L. Shiffman, W. Graham E. Cooksley, Geoffrey Dusheiko, Samuel S. Lee, Luis A. Balart, Robert Reindollar, K. Rajender Reddy, Teresa L. Wright, Amy Lin,
New England Journal of Medicine

Abstract

In patients with chronic hepatitis C and cirrhosis or bridging fibrosis, 180 microg of peginterferon alfa-2a administered once weekly is significantly more effective than 3 million units of standard interferon alfa-2a administered three times weekly.

References

YearCitations

Page 1